U.S. Markets closed

How This Biotech Giant Is Using Machine Learning In Liver Disease

ALLISON GATLIN
How This Biotech Giant Is Using Machine Learning In Liver Disease

Gilead Sciences announced a collaboration Tuesday to use machine learning to seek new treatment options for a progressive liver disease. It will pay Insitro $15 million upfront for the deal.